Lv51
862 积分 2021-03-03 加入
Epigenetic Therapies for Cancer
14分钟前
待确认
A multicentre trial of intensive immunosuppressive therapy combined with umbilical cord blood for the treatment of severe aplastic anaemia
5天前
已完结
Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms
7天前
已完结
Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation
7天前
已完结
Evaluation of thrombotic events in patients with immune thrombocytopenia
8天前
已完结
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
20天前
已完结
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
30天前
已完结
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome
1个月前
已完结
A prospective phase 2 study of combination epigenetic therapy against relapsed/refractory peripheral T cell lymphoma
1个月前
已完结
International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
2个月前
已完结
皖公网安备34019202002308
